Synthesis and Characterization of 1H-Phenanthro[9,10-d]imidazole Derivatives As Multifunctional Agents for Treatment of Alzheimer's Disease.
Jinggong Liu,Jun Qiu,Mingxue Wang,Ling Wang,Lijuan Su,Jinbo Gao,Qiong Gu,Jun Xu,Shi-Liang Huang,Lian-Quan Gu,Zhi-Shu Huang,Ding Li
DOI: https://doi.org/10.1016/j.bbagen.2014.05.005
IF: 4.117
2014-01-01
Biochimica et Biophysica Acta (BBA) - General Subjects
Abstract:Background: Alzheimer's disease (AD) is a progressive neurodegenerative brain disorder that is characterized by dementia, cognitive impairment, and memory loss. Diverse factors are related to the development of AD, such as increased level of beta-amyloid (A beta), acetylcholine, metal ion deregulation, hyperphosphorylated tau protein, and oxidative stress.Methods: The following methods were used: organic syntheses of 1H-phenanthro[9,10-d]imidazole derivatives, inhibition of self-mediated and metal-induced A beta(1-42) aggregation, inhibition studies for acetylcholinesterase and butyrylcholinesterase, anti-oxidation activity studies, CD, MTT assay, transmission electron microscopy, dot plot assay, gel electrophoresis, Western blot, and molecular docking studies.Results: We synthesized and characterized a new type of 1H-phenanthro[9,10-d]imidazole derivatives as multifunctional agents for AD treatment Our results showed that most of these derivatives exhibited strong A beta aggregation inhibitory activity. Compound 9g had 74% A beta(1-42) aggregation inhibitory effect at 10 mu M concentration with its IC50 value of 6.5 mu M for self-induced A beta(1-42) aggregation. This compound also showed good inhibition of metal-mediated (Cu2+ and Fe2+) and acetylcholinesterase-induced A beta(1-42) aggregation, as indicated by using thioflavin T assay, transmission electron microscopy, gel electrophoresis, and Western blot. Besides, compound 9g exhibited cholinesterase inhibitory activity, with its IC50 values of 0.86 mu M and 0.51 mu M for acetylcholinesterase and butyrylcholinesterase, respectively. In addition, compound 9g showed good anti-oxidation effect with oxygen radical absorbance capacity (ORAC) value of 2.29.Conclusions: Compound 9g was found to be a potent multi-target-directed agent for Alzheimer's disease.General significance: Compound 9g could become a lead compound for further development as a multi-target-directed agent for AD treatment. (C) 2014 Elsevier B.V. All rights reserved.